News

The Ark Invest founder is betting big on SpaceX.

Suze Orman walked through a real SpaceX IPO trade that turned $10,000 into roughly $5,600 in seven weeks, and her lesson has nothing to do with rockets or Elon Musk.

Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.

Which of these three high-tech market newcomers is the best?

Is the hot IPO stock finally a bargain?

Video podcasting and gaming could be revenue generators for Netflix, but there isn't anything on the immediate horizon to help reverse stock price losses.

The new CEO took over the conglomerate with a massive nest egg that he must try to deploy.

Chipotle shares shot up after strong Q2 earnings, but Starbucks stock could be the better buy.

Like SpaceX, five of the seven Magnificent Seven stocks sank below their IPO price during the first year after their IPO.

(Bloomberg) -- Apnimed Inc., a late-stage drug developer focused on sleep apnea rose 6.3% on Friday after raising $192 million in an upsized US initial public offering.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapUS Strikes Iran Again as Conflict Spreads Across Middle Ea

AbbVie lowered its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the recent quarter.

The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%

A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.

A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.

A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.

Chipotle Mexican Grill raised its 2026 comparable sales growth outlook to low single-digit range.

Chipotle Mexican Grill managed to beat earnings and revenue estimates, but margins and labor pose a challenge for the burrito chain.

Yahoo Finance Senior Business Reporter Brooke DiPalma joins Josh Lipton on Asking for a Trend to break down Chipotle's (CMG) second quarter earnings results, including the company's latest performance, consumer trends, and what investors should watch next.

Short interest in the stock keeps climbing, but Musk says those betting against SpaceX have a ‘very low’ chance of surviving.

China's CXMT just pulled off the biggest semiconductor IPO in mainland history, and Micron shareholders felt the tremors almost immediately. Whether that reaction is panic or opportunity depends on one critical gap between the two chipmakers.

Circle announced it has acquired more than 680 blockchain patent families and nearly 1,000 issued patents from IBM's blockchain portfolio.

Sometimes three’s a crowd. But when it comes to the memory boom there’s room, and plenty of demand, for more chip makers.

Private-market platforms are giving accredited investors new ways to buy pre-IPO companies like SpaceX

Nio received about 18.24 million CXMT shares, though the stake is subject to an 18-month lockup.

Space Exploration Technologies stock is down big: Time to buy the dip?

Gene-editing biotech debuts at $25, backed by Sanofi and Eli Lilly, with a roughly $440.3 million valuation.

UiPath's stock has been left for dead, yet several of enterprise software's biggest players have compelling reasons to want it. Five names stand out as potential acquirers, and the logic behind one of them is almost impossible to argue against.

Short interest in the stock keeps climbing, but Musk says those betting against SpaceX have a ‘very low’ chance of surviving.

Based on the tables and data, we can expect a lot of volatility

Strong biotech returns, major pharma acquisitions and new IPO filings are reshaping the 2026 U.S. listing market.